KM Biologics plays a key role in safeguarding the health of Japan’s population, developing cutting-edge vaccines and blood-plasma products, and screening newborn babies.
Takuya Maoka, President of KNC Laboratories, discusses the dynamic landscape of the Japanese chemical industry, emphasizing a shift towards specialization, particularly in semiconductor chemicals. In...
Specializing in healthcare and life sciences, Dojin is poised to be a key player not only in the Japanese biotechnology field, but worldwide as it leverages the synergistic benefits of its group company...
